Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZBTB46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRRC2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC107984534 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR2F6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSUN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZMYND19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSUN5P2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLA2G4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSBPL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NREP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC60 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on